Differential prognostic factors in low‐ and high‐burden de novo metastatic hormone‐sensitive prostate cancer patients

Metastatic burden is a critical factor for therapy decision‐making in metastatic hormone‐sensitive prostate cancer. The present study aimed to identify prognostic factors in men with high‐ or low‐metastatic burden treated with primary androgen‐deprivation therapy. The study included 2450 men with de...

Descripción completa

Detalles Bibliográficos
Autores principales: Shiota, Masaki, Terada, Naoki, Saito, Toshihiro, Yokomizo, Akira, Kohei, Naoki, Goto, Takayuki, Kawamura, Sadafumi, Hashimoto, Yasuhiro, Takahashi, Atsushi, Kimura, Takahiro, Tabata, Ken‐ichi, Tomida, Ryotaro, Hashimoto, Kohei, Sakurai, Toshihiko, Shimazui, Toru, Sakamoto, Shinichi, Kamiyama, Manabu, Tanaka, Nobumichi, Mitsuzuka, Koji, Kato, Takuma, Narita, Shintaro, Yasumoto, Hiroaki, Teraoka, Shogo, Kato, Masashi, Osawa, Takahiro, Nagumo, Yoshiyuki, Matsumoto, Hiroaki, Enokida, Hideki, Sugiyama, Takayuki, Kuroiwa, Kentaro, Inoue, Takahiro, Mizowaki, Takashi, Kamoto, Toshiyuki, Kojima, Takahiro, Kitamura, Hiroshi, Sugimoto, Mikio, Nishiyama, Hiroyuki, Eto, Masatoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
ORIGINAL ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8019198/
https://www.ncbi.nlm.nih.gov/pubmed/33159829
http://dx.doi.org/10.1111/cas.14722

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8019198/
https://www.ncbi.nlm.nih.gov/pubmed/33159829
http://dx.doi.org/10.1111/cas.14722

Ejemplares similares